Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EFNA1,Ephrin-A1,Inverse variance weighted,15,1.00 [0.95-1.06],0.907002050221329
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.10 [0.95-1.27],0.20057846567835
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.97 [0.90-1.04],0.369093530282159
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MDK,Midkine,Inverse variance weighted,19,1.19 [1.11-1.27],1.36489618391128e-07
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,0.99 [0.96-1.03],0.761882671369033
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PALM2,Paralemmin-2,Inverse variance weighted,9,1.03 [0.96-1.10],0.376562226916534
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,50,0.98 [0.96-1.01],0.156148551696962
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GAST,Gastrin,Inverse variance weighted,9,0.98 [0.90-1.07],0.717498260085
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.04 [0.98-1.11],0.207077764566011
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.96 [0.87-1.05],0.388064272666083
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL15,Interleukin-15,Inverse variance weighted,35,0.98 [0.92-1.04],0.493111445985604
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.04 [0.76-1.42],0.807809384539006
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LMNB2,Lamin-B2,Inverse variance weighted,9,1.12 [1.00-1.26],0.0439426124940717
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,34,1.03 [1.00-1.07],0.0827569368616233
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.13 [0.88-1.44],0.335479724708118
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.24 [0.88-1.74],0.218770289856283
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.00 [0.97-1.04],0.966047273968424
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,10,1.09 [1.00-1.18],0.0540798857153796
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AMBP,Protein AMBP,Inverse variance weighted,5,1.05 [0.93-1.19],0.417503700518839
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.92 [0.87-0.98],0.0076028002548601
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.07 [0.94-1.22],0.290853781493198
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,1.00 [0.80-1.23],0.965791142205906
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD83,CD83 antigen,Inverse variance weighted,19,1.00 [0.92-1.07],0.899894375577536
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,40,1.03 [0.99-1.07],0.182102113007107
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,1.02 [0.93-1.11],0.718786597186521
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.99 [0.90-1.10],0.901060887553766
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,28,1.01 [0.96-1.07],0.690845908715413
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",COLEC12,Collectin-12,Inverse variance weighted,13,1.05 [0.94-1.17],0.407280723344451
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PSAP,Prosaposin,Inverse variance weighted,13,0.97 [0.91-1.03],0.264575015372379
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MSLN,Mesothelin,Inverse variance weighted,36,0.99 [0.96-1.02],0.362143907429808
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.97 [0.89-1.06],0.520067360841875
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,1.02 [0.98-1.06],0.441220723990489
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,1.00 [0.90-1.11],0.969981436542096
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.02 [0.99-1.05],0.290887873928154
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS9,Galectin-9,Inverse variance weighted,39,1.00 [0.97-1.03],0.932592320456789
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.02 [0.89-1.17],0.775760695761276
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,0.84 [0.66-1.08],0.176383678018235
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.95 [0.75-1.22],0.695566236487309
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,1.06 [0.89-1.26],0.499677093894205
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",REN,Renin,Inverse variance weighted,12,0.97 [0.92-1.02],0.292714497586152
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.07 [0.95-1.20],0.274896129317152
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.87-1.12],0.836980711992534
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,1.01 [0.99-1.03],0.568223392980846
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGA11,Integrin alpha-11,Inverse variance weighted,16,1.03 [0.99-1.08],0.178697779658985
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PVR,Poliovirus receptor,Inverse variance weighted,32,1.00 [0.98-1.02],0.882908193047115
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGAM,Integrin alpha-M,Inverse variance weighted,15,0.95 [0.89-1.01],0.0767625927050294
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.03 [0.97-1.10],0.330181208585889
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.00 [0.95-1.05],0.965339379885342
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.00 [0.96-1.04],0.955222479864924
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.02 [0.94-1.10],0.634442935801694
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.00 [0.90-1.10],0.94600302551247
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PRSS8,Prostasin,Inverse variance weighted,19,0.99 [0.91-1.06],0.70732544657754
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,0.98 [0.91-1.05],0.526165686031735
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,0.99 [0.94-1.03],0.561099941295253
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TFF2,Trefoil factor 2,Inverse variance weighted,16,1.02 [0.95-1.09],0.607964374653524
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.05 [0.97-1.14],0.237818502073017
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.03 [1.00-1.06],0.0416642815669156
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PGA4,Pepsin A-4,Inverse variance weighted,9,1.04 [0.90-1.19],0.610123910301645
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.00 [0.94-1.05],0.897970970792991
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",EFNA4,Ephrin-A4,Inverse variance weighted,5,0.91 [0.77-1.07],0.268674963796372
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.00 [0.94-1.08],0.923676562068456
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.01 [0.97-1.06],0.595143728881095
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGB2,Integrin beta-2,Inverse variance weighted,20,0.95 [0.90-1.01],0.0828762313455912
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.02 [0.97-1.07],0.445901178089226
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.99 [0.97-1.01],0.278554135690193
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CA14,Carbonic anhydrase 14,Inverse variance weighted,21,0.99 [0.89-1.11],0.91782189458359
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.99 [0.96-1.03],0.78408627131783
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AREG,Amphiregulin,Inverse variance weighted,7,1.02 [0.89-1.17],0.759140450149498
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CTSL,Cathepsin L1,Inverse variance weighted,29,1.05 [1.00-1.12],0.0620661640346995
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",OCLN,Occludin,Inverse variance weighted,3,0.94 [0.81-1.09],0.43766427101347
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AGRN,Agrin,Inverse variance weighted,31,0.98 [0.94-1.02],0.233296978369835
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.05 [0.99-1.10],0.0918697903489139
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.98-1.04],0.618655690695085
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,1.00 [0.96-1.04],0.890819904960669
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.02 [0.99-1.05],0.306931990591603
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,0.97 [0.92-1.02],0.233590454173067
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.99 [0.93-1.06],0.851012366248505
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,1.00 [0.94-1.06],0.888699222296172
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CSTB,Cystatin-B,Inverse variance weighted,25,0.99 [0.95-1.02],0.506891976230391
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.01 [0.98-1.04],0.447589487451467
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CA6,Carbonic anhydrase 6,Inverse variance weighted,51,0.99 [0.96-1.01],0.297520693942441
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.91 [0.82-1.02],0.118771754135216
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",HGF,Hepatocyte growth factor,Inverse variance weighted,7,1.02 [0.89-1.17],0.751676601943893
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TFF3,Trefoil factor 3,Inverse variance weighted,10,1.00 [0.91-1.10],0.972287539020726
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ELN,Elastin,Inverse variance weighted,12,1.06 [0.93-1.20],0.365763402111959
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,1.02 [0.99-1.06],0.218316656653131
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.05 [0.87-1.26],0.621066496137184
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.95 [0.88-1.03],0.190866488458427
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.96 [0.86-1.08],0.534677528515966
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.04 [0.96-1.13],0.335450428165772
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.96 [0.84-1.11],0.605546767670601
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.02 [0.97-1.07],0.376231189384353
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.04 [1.01-1.08],0.0161183967019237
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.98-1.03],0.58818032733641
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.02 [0.93-1.11],0.706049360353528
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CPM,Carboxypeptidase M,Inverse variance weighted,23,1.00 [0.93-1.07],0.965873757733441
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.02 [0.98-1.05],0.382557767085398
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.04 [0.93-1.16],0.513800067964281
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,1.00 [0.90-1.11],0.95850063603384
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,28,0.98 [0.94-1.02],0.331358460471274
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.97 [0.89-1.07],0.590832749426497
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.09 [0.90-1.33],0.383659209761716
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS4,Galectin-4,Inverse variance weighted,19,0.96 [0.92-0.99],0.0182396984776458
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.99 [0.87-1.14],0.912239485521268
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.96 [0.92-1.01],0.114285048902588
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MMP7,Matrilysin,Inverse variance weighted,15,1.03 [0.99-1.07],0.134623100233581
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LGALS3,Galectin-3,Inverse variance weighted,42,1.00 [0.97-1.03],0.970651976376209
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.00 [0.98-1.03],0.974107121026045
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SEPTIN8,Septin-8,Inverse variance weighted,6,1.02 [0.91-1.13],0.758763227903331
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,1.14 [0.94-1.39],0.172135196001272
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.02 [0.97-1.07],0.498113083805555
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,36,0.98 [0.95-1.02],0.308100736909425
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SHISA5,Protein shisa-5,Inverse variance weighted,16,1.07 [0.98-1.18],0.143544254571681
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.99 [0.95-1.03],0.630864997604524
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.01 [0.91-1.12],0.839455995095949
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ITGAV,Integrin alpha-V,Inverse variance weighted,14,0.98 [0.91-1.06],0.598865950506409
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.03 [0.88-1.20],0.732896001674334
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.00 [0.97-1.04],0.910260783447847
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAYN,Layilin,Inverse variance weighted,23,0.99 [0.95-1.03],0.550833183099728
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.88-1.05],0.34248137821378
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.97 [0.91-1.03],0.279491784658831
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.83 [0.68-1.03],0.0854625251537651
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,0.97 [0.94-1.00],0.0222359048878766
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,0.98 [0.87-1.10],0.70389167771435
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHGA,Chromogranin-A,Inverse variance weighted,8,1.00 [0.94-1.07],0.95128844244539
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",FAP,Prolyl endopeptidase FAP,Inverse variance weighted,13,1.03 [0.98-1.08],0.223512461385509
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.91 [0.85-0.98],0.0104883718797508
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.02 [0.90-1.16],0.747977653491805
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.99 [0.93-1.05],0.711248046052254
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,1.02 [0.96-1.08],0.544041511048386
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.01 [0.95-1.08],0.681391762348259
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.91 [0.77-1.06],0.232623434405679
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NECTIN2,Nectin-2,Inverse variance weighted,8,1.03 [0.98-1.08],0.269392637318068
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.09 [0.95-1.26],0.209908330701262
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.08 [0.99-1.17],0.0935278459204967
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.05 [0.94-1.17],0.39258887320529
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CD302,CD302 antigen,Inverse variance weighted,17,0.96 [0.92-1.01],0.0935139543739094
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,1.00 [0.96-1.04],0.945267838213216
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,1.09 [1.04-1.15],0.0010214745517351
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,1.04 [1.00-1.08],0.0515959156992302
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.03 [0.97-1.10],0.355410625040929
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,1.01 [0.94-1.08],0.740105363310048
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.99 [0.92-1.07],0.867129559664375
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.02 [0.97-1.07],0.531524133927556
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.97 [0.91-1.03],0.345285768086283
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.97 [0.85-1.12],0.70585651395241
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.95 [0.88-1.03],0.217169679699601
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.03 [0.98-1.09],0.247673246734102
Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.01 [0.98-1.03],0.568185518653195
